SentinelOne says macOS.Gaslight uses prompt injection to mislead AI-based malware analysis, steal data, and use Telegram for ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Galderma Group (SWX:GALD) is back in focus after reporting record 2025 results, with net ...

Good day, and thank you for standing by. Welcome to Galderma's conference call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the ...

Galderma has significantly raised its peak annual sales estimate for Nemluvio (nemolizumab) to more than $4 billion, doubling its previous projection of more than $2 billion. The update follows what ...

Nemluvio, approved for the skin-itching conditions prurigo nodularis and atopic dermatitis, generated $452 million in net sales in its first full year, up from $23 million in 2024. The drug held ...

Galderma, the pure-play dermatology category leader, announced new data from the OLYMPIA open-label extension study investigating the long-term safety and efficacy of Nemluvio in moderate-to-severe ...

“Prurigo nodularis is not only intensely itchy, painful and uncomfortable, it can also take a profound toll on sleep, emotional wellbeing, and daily functioning. That's why achieving sustained, ...

The OLYMPIA LTE study was designed to assess the safety and efficacy of Nemluvio in patients with prurigo nodularis up to four years and included 508 patients from the phase II trial and the OLYMPIA 1 ...